BMS-234475: Bristol-Myers will begin within the next two months a Phase II trial

Bristol-Myers Squibb Co., Princeton, N.J.
Product: BMS-234475 peptidomimetic HIV protease

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE